A randomized, controlled non-inferiority study assessing the safety and efficacy of HHPG-19K for prophylaxis of chemotherapy-induced neutropenia in patients with lymphoma
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Mecapegfilgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- 09 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress